Inflammation in Abdominal Aortic Aneurysm: Cause or Comorbidity?

Area of Science:

• Cardiovascular Biology
• Immunology
• Vascular Medicine

Background:

• Abdominal aortic aneurysm (AAA) is a life-threatening condition characterized by chronic aortic wall degeneration.
• The pathogenesis involves inflammation, immune system activation, extracellular matrix remodeling, and cellular changes.
• Inflammatory cells play a critical role in the development and progression of AAA.

Purpose of the Study:

• To review the specific roles of various inflammatory cells in abdominal aortic aneurysm.
• To highlight the contribution of immune cells to aneurysm formation and expansion.
• To discuss the therapeutic implications and limitations of anti-inflammatory strategies.

Main Methods:

• Review of existing studies on human aneurysmal specimens.
• Analysis of findings from relevant animal models of aortic aneurysm.
• Synthesis of data on inflammatory cell types and their functions in AAA.

Main Results:

• Multiple inflammatory cell types, including leukocytes (neutrophils, macrophages), natural killer cells, dendritic cells, T cells, and B cells, are implicated in AAA.
• These cells and their associated signaling pathways significantly contribute to aneurysm development and expansion.
• Despite their known roles, anti-inflammatory therapies have shown limited success.

Conclusions:

• Inflammatory cells are central to abdominal aortic aneurysm pathogenesis.
• Targeting inflammatory pathways is crucial, but current monotherapies are insufficient.
• Combined therapeutic strategies targeting multiple pathways may be necessary for effective AAA treatment.